- Home
- DLHC vs ATRA Comparison
DLHC vs ATRA Comparison
Compare DLHC & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLHC
- ATRA
- Stock Information
- Founded
- DLHC 1969
- ATRA 2012
- Country
- DLHC United States
- ATRA United States
- Employees
- DLHC N/A
- ATRA N/A
- Industry
- DLHC Business Services
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DLHC Consumer Discretionary
- ATRA Health Care
- Exchange
- DLHC Nasdaq
- ATRA Nasdaq
- Market Cap
- DLHC 79.7M
- ATRA 67.9M
- IPO Year
- DLHC N/A
- ATRA 2014
- Fundamental
- Price
- DLHC $5.93
- ATRA $12.64
- Analyst Decision
- DLHC
- ATRA Strong Buy
- Analyst Count
- DLHC 0
- ATRA 3
- Target Price
- DLHC N/A
- ATRA $21.00
- AVG Volume (30 Days)
- DLHC 32.4K
- ATRA 52.6K
- Earning Date
- DLHC 08-06-2025
- ATRA 08-11-2025
- Dividend Yield
- DLHC N/A
- ATRA N/A
- EPS Growth
- DLHC 80.25
- ATRA N/A
- EPS
- DLHC 0.31
- ATRA 0.56
- Revenue
- DLHC $359,723,000.00
- ATRA $188,667,000.00
- Revenue This Year
- DLHC N/A
- ATRA N/A
- Revenue Next Year
- DLHC N/A
- ATRA N/A
- P/E Ratio
- DLHC $18.18
- ATRA $22.21
- Revenue Growth
- DLHC N/A
- ATRA 202.41
- 52 Week Low
- DLHC $2.72
- ATRA $5.01
- 52 Week High
- DLHC $10.88
- ATRA $18.71
- Technical
- Relative Strength Index (RSI)
- DLHC 66.14
- ATRA 60.49
- Support Level
- DLHC $5.50
- ATRA $11.70
- Resistance Level
- DLHC $5.60
- ATRA $12.75
- Average True Range (ATR)
- DLHC 0.13
- ATRA 0.74
- MACD
- DLHC 0.04
- ATRA -0.00
- Stochastic Oscillator
- DLHC 100.00
- ATRA 76.60
About DLHC DLH Holdings Corp.
DLH Holdings Corp is a provider of technology-enabled business process outsourcing and program management solutions in the United States. The company offers services to several government agencies which include the Department of Veteran Affairs. The company is engaged in public health, performance evaluation, and health operations to solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, analytics, cloud-based applications, telehealth systems, and others.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).